Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:ADUS NASDAQ:FTRE NASDAQ:PRVA NASDAQ:WGS On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeADUSAddus HomeCare$106.96+1.9%$111.80$88.96▼$136.72$1.93B0.8136,965 shs168,659 shsFTREFortrea$6.42+17.6%$5.30$3.97▼$26.59$494.13M1.811.90 million shs3.23 million shsPRVAPrivia Health Group$19.47+3.2%$21.55$16.47▼$26.09$2.30B0.8837,203 shs944,992 shsWGSGeneDx$108.35+6.6%$80.76$25.32▼$117.75$2.90B2.021.01 million shs924,686 shs7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceADUSAddus HomeCare+1.91%-1.97%-4.38%-1.92%-11.10%FTREFortrea+17.58%-6.55%+22.87%+16.52%-75.76%PRVAPrivia Health Group+3.23%-1.17%-11.94%-14.30%-2.60%WGSGeneDx+6.64%+27.61%+18.27%+71.25%+260.33%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationADUSAddus HomeCare4.9364 of 5 stars3.63.00.05.04.02.53.1FTREFortrea4.1471 of 5 stars4.03.00.00.02.30.83.8PRVAPrivia Health Group3.6714 of 5 stars3.54.00.00.01.43.31.9WGSGeneDx3.0192 of 5 stars1.44.00.00.03.15.01.9Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceADUSAddus HomeCare 3.25Buy$142.5733.29% UpsideFTREFortrea 1.93Reduce$13.73113.82% UpsidePRVAPrivia Health Group 3.00Buy$28.3845.79% UpsideWGSGeneDx 2.75Moderate Buy$101.63-6.21% DownsideCurrent Analyst Ratings BreakdownLatest FTRE, PRVA, WGS, and ADUS Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails8/4/2025FTREFortreaRobert W. BairdSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeNeutral ➝ Outperform$7.00 ➝ $9.008/4/2025WGSGeneDxPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$110.00 ➝ $120.007/30/2025WGSGeneDxWells Fargo & CompanySubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetEqual Weight ➝ Equal Weight$78.00 ➝ $95.007/16/2025ADUSAddus HomeCareJMP SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingMarket Outperform ➝ Market Outperform$150.007/11/2025FTREFortreaMizuhoSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$8.00 ➝ $7.007/9/2025FTREFortreaEvercore ISISubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetIn-Line ➝ In-Line$6.00 ➝ $5.007/9/2025PRVAPrivia Health GroupEvercore ISISubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOutperform ➝ Outperform$30.00 ➝ $28.007/9/2025WGSGeneDxPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageOverweight$110.006/30/2025WGSGeneDxGuggenheimSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$88.00 ➝ $115.006/20/2025ADUSAddus HomeCareJMP SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingMarket Outperform ➝ Market Outperform$150.006/10/2025ADUSAddus HomeCareMacquarieSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform ➝ Outperform$133.00(Data available from 8/5/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookADUSAddus HomeCare$1.15B1.70$5.49 per share19.47$53.52 per share2.00FTREFortrea$2.70B0.22$1.85 per share3.47$15.19 per share0.42PRVAPrivia Health Group$1.74B1.37$0.19 per share104.52$5.70 per share3.42WGSGeneDx$362.32M8.53$1.09 per share99.29$8.75 per share12.38Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateADUSAddus HomeCare$73.60M$4.4324.1419.961.496.52%9.23%6.96%N/AFTREFortrea-$328.50M-$8.79N/A5.020.37-29.43%2.84%1.06%8/6/2025 (Estimated)PRVAPrivia Health Group$14.39M$0.12162.2672.113.020.87%2.32%1.38%8/7/2025 (Estimated)WGSGeneDx-$52.29M$0.052,167.0051.84N/A0.39%16.51%9.35%N/ALatest FTRE, PRVA, WGS, and ADUS EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/7/2025Q2 2025PRVAPrivia Health Group$0.05N/AN/AN/A$466.97 millionN/A8/6/2025Q2 2025FTREFortrea$0.06N/AN/AN/A$631.61 millionN/A8/4/2025Q2 2025ADUSAddus HomeCare$1.45$1.49+$0.04$1.20$345.71 million$349.44 million7/29/2025Q2 2025WGSGeneDx$0.10$0.50+$0.40$0.36$86.00 million$102.69 million5/12/2025Q1 2025FTREFortrea-$0.07$0.02+$0.09-$6.25$609.63 million$651.30 million5/5/2025Q1 2025ADUSAddus HomeCare$1.33$1.42+$0.09$1.16$341.66 million$337.71 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthADUSAddus HomeCareN/AN/AN/AN/AN/AFTREFortreaN/AN/AN/AN/AN/APRVAPrivia Health GroupN/AN/AN/AN/AN/AWGSGeneDxN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioADUSAddus HomeCare0.201.741.74FTREFortrea1.220.970.97PRVAPrivia Health GroupN/A1.881.88WGSGeneDx0.192.872.70Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipADUSAddus HomeCare95.35%FTREFortreaN/APRVAPrivia Health Group94.48%WGSGeneDx61.72%Insider OwnershipCompanyInsider OwnershipADUSAddus HomeCare4.60%FTREFortrea0.38%PRVAPrivia Health Group10.70%WGSGeneDx29.60%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableADUSAddus HomeCare49,70318.40 million17.55 millionOptionableFTREFortrea15,50090.50 million90.16 millionOptionablePRVAPrivia Health Group1,140121.92 million108.88 millionOptionableWGSGeneDx1,20028.53 million20.09 millionOptionableFTRE, PRVA, WGS, and ADUS HeadlinesRecent News About These CompaniesAlberta Investment Management Corp Buys New Shares in GeneDx Holdings Corp. (NASDAQ:WGS)1 hour ago | marketbeat.comGeneDx Holdings Corp. (NASDAQ:WGS) Position Increased by TD Asset Management Inc1 hour ago | marketbeat.comEnvestnet Asset Management Inc. Buys 4,178 Shares of GeneDx Holdings Corp. (NASDAQ:WGS)1 hour ago | marketbeat.comRosen Law Firm Encourages GeneDx Holdings Corp. ...August 3 at 1:43 PM | gurufocus.comRosen Law Firm Encourages GeneDx Holdings Corp. Investors to Inquire About Securities Class Action Investigation - WGSAugust 3 at 12:43 PM | prnewswire.comGeneDx (NASDAQ:WGS) Upgraded by Wall Street Zen to Buy RatingAugust 3 at 3:44 AM | marketbeat.comWGS Investor News: If You Have Suffered Losses in GeneDx Holdings Corp. ...August 2 at 1:17 PM | gurufocus.comWGS Investor News: If You Have Suffered Losses in GeneDx Holdings Corp. (NASDAQ: WGS), You Are Encouraged to Contact The Rosen Law Firm About Your RightsAugust 2 at 12:52 PM | globenewswire.com15,317 Shares in GeneDx Holdings Corp. (NASDAQ:WGS) Acquired by Universal Beteiligungs und Servicegesellschaft mbHAugust 2 at 4:50 AM | marketbeat.comWells Fargo & Company Forecasts Strong Price Appreciation for GeneDx (NASDAQ:WGS) StockAugust 2 at 2:07 AM | americanbankingnews.comKevin Feeley Sells 388 Shares of GeneDx Holdings Corp. (NASDAQ:WGS) StockAugust 1, 2025 | marketbeat.comGeneDx Holdings Corp. (NASDAQ:WGS) CEO Sells $226,837.74 in StockAugust 1, 2025 | marketbeat.comVictory Capital Management Inc. Purchases 12,945 Shares of GeneDx Holdings Corp. (NASDAQ:WGS)August 1, 2025 | marketbeat.comGeneDx Holdings Corp. (NASDAQ:WGS) CFO Sells $40,860.28 in StockAugust 1, 2025 | insidertrades.comGeneDx Surges Past Q2 Expectations, Sets Up For Strong Year-End GrowthJuly 31, 2025 | seekingalpha.comGeneDx Target of Unusually Large Options Trading (NASDAQ:WGS)July 31, 2025 | marketbeat.comWells Fargo & Company Issues Positive Forecast for GeneDx (NASDAQ:WGS) Stock PriceJuly 31, 2025 | marketbeat.comWGS Investors Have Opportunity to Join GeneDx Holdings Corp. Investigation With the DJS Law GroupJuly 31, 2025 | prnewswire.comWhy GeneDx Holdings Stock Crushed It Again TodayJuly 30, 2025 | fool.comGeneDx Holdings Corp. Investors: Company Investigated by the Portnoy Law FirmJuly 30, 2025 | globenewswire.comGeneDx (NASDAQ:WGS) Shares Gap Up Following Strong EarningsJuly 30, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeFTRE, PRVA, WGS, and ADUS Company DescriptionsAddus HomeCare NASDAQ:ADUS$106.96 +2.00 (+1.91%) Closing price 08/4/2025 04:00 PM EasternExtended Trading$106.97 +0.01 (+0.01%) As of 08/4/2025 07:36 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living. This segment offers services that include assistance with bathing, grooming, oral care, feeding and dressing, medication reminders, meal planning and preparation, housekeeping, and transportation services. The Hospice segment provides palliative nursing care, social work, spiritual counseling, homemaker, and bereavement counseling services for people who are terminally ill, as well as related services for their families. The Home Health segment offers skilled nursing and physical, occupational, and speech therapy for the individuals who requires assistance during an illness or after hospitalization. The company's payor clients include federal, state, and local governmental agencies; managed care organizations; commercial insurers; and private individuals. Addus HomeCare Corporation was founded in 1979 and is headquartered in Frisco, Texas.Fortrea NASDAQ:FTRE$6.42 +0.96 (+17.58%) Closing price 08/4/2025 04:00 PM EasternExtended Trading$6.38 -0.04 (-0.69%) As of 04:28 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Fortrea Holdings Inc., a contract research organization, primarily engages in the provision of biopharmaceutical product and medical device development services worldwide. The company operates through two segments: Clinical Services and Enabling Services. The Clinical Services segment provides across the clinical pharmacology and clinical development spectrum. The Enabling Services segment provides patient access and clinical trial technology solutions to customers that streamline complex randomization and optimize the trial drug supply process. The company offers delivery models that include full service, functional service provider, and hybrid service structures. It also offers phase I-IV clinical trial management, differentiated technology enabled trial solutions, and post approval services, as well as consulting services. The company serves pharmaceutical, biotechnology, and medical device organizations. Fortrea Holdings Inc. was incorporated in 2023 and is headquartered in Durham, North Carolina.Privia Health Group NASDAQ:PRVA$19.47 +0.61 (+3.23%) Closing price 08/4/2025 04:00 PM EasternExtended Trading$20.70 +1.23 (+6.32%) As of 04:01 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings. It offers technology and population health tools to enhance independent providers' workflows; management services organization that enable providers to focus on their patients by reducing administrative work; single-TIN medical group that facilitates payer negotiation, clinical integration and alignment of financial incentives; accountable care organization, which engage patients, reduce inappropriate utilization, and enhance coordination and patient quality metrics to drive value-based care; and network for purchasers and payers that enable providers to connect with new patient populations and create custom contracts. The company was founded in 2007 and is headquartered in Arlington, Virginia.GeneDx NASDAQ:WGS$108.35 +6.75 (+6.64%) Closing price 08/4/2025 04:00 PM EasternExtended Trading$105.68 -2.67 (-2.46%) As of 07:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.GeneDx Holdings Corp., through its subsidiaries, provides genomics-related diagnostic and information services. The company offers Centrellis, an AI-driven health intelligence platform that integrates digital tools and artificial intelligence allowing scientists to ingest and synthesize clinical and genomic data to deliver comprehensive health insights. It provides genetic diagnostic tests, screening solutions, and information with a focus on pediatrics, rare diseases for children and adults, and hereditary cancer screening. GeneDx Holdings Corp. was founded in 2017 and is headquartered in Stamford, Connecticut. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas How 2 Deals in 48 Hours Changed Everything for Joby Aviation Here's Why Traders Turned Bullish on Boeing Stock Onsemi’s August Pullback Is a Signal to Buy for Tech Investors Strategy Insiders Buy In While Analysts Predict Big Upside Analysts Make a Quantum Bet on D-Wave's Cryogenic Packaging Yes, You Can Get Dividends in Tech: 3 Stocks With Yield + Upside MarketBeat Week in Review – 07/28 - 08/01 Alphabet Gains Momentum as Sentiment on Wall Street Improves Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
